BrdU drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (9)
Papers in which this entity is mentioned.
- Multigenerational cell tracking of DNA replication and heritable DNA damage. (2025)
- The Application of Long-Read Sequencing to Cancer. (2024)
- Structural variation in the sequencing era. (2020)
- Reciprocal monoallelic expression of ASAR lncRNA genes controls replication timing of human chromosome 6. (2020)
- Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways. (2019)
- A germline polymorphism of thymine DNA glycosylase induces genomic instability and cellular transformation. (2014)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
- Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
- LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. (2013)
Merged raw entities (7)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| brdu | drug | 61 | 346 |
| bromodeoxyuridine | drug | 22 | 27 |
| 5-bromo-2'-deoxyuridine | drug | 1 | 1 |
| 5 μm brdu | drug | — | — |
| brdu+ | drug | — | — |
| brdu-ir | drug | — | — |
| brdu slow-release pellet | drug | — | — |